The impact of the 21-gene Recurrence Score® assay upon physician treatment recommendations in the neoadjuvant setting in lymph node-negative breast cancer patients in a multicenter prospective study in Quebec

被引:0
|
作者
Yordanova, Mariya
Sideris, Lucas
Dube, Pierre
Boileau, Jean-Francois
Lemieux, Julie
Mihalcioiu, Catalin
Levesque, Sylvie
Guertin, Marie-Claude
Patocskai, Erica
Younan, Rami
Robidoux, Andre
Hassan, Saima
机构
关键词
D O I
10.1158/1538-7445.SABCS22-P6-01-39
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P6-01-39
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Clinical relevance of the 21-gene Recurrence Score® assay in treatment decisions for patients with node-positive breast cancer in the genomic era
    Eleftherios P. Mamounas
    Christy A. Russell
    Anna Lau
    Michelle P. Turner
    Kathy S. Albain
    npj Breast Cancer, 4
  • [42] First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer
    Dieci, Maria Vittoria
    Guarneri, Valentina
    Giarratano, Tommaso
    Mion, Marta
    Tortora, Giampaolo
    De Rossi, Costanza
    Gori, Stefania
    Oliani, Cristina
    Merlini, Laura
    Pasini, Felice
    Bonciarelli, Giorgio
    Griguolo, Gaia
    Orvieto, Enrico
    Michieletto, Silvia
    Saibene, Tania
    Del Bianco, Paola
    De Salvo, Gian Luca
    Conte, PierFranco
    ONCOLOGIST, 2018, 23 (03): : 297 - 305
  • [43] Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26–30
    Seho Park
    Yunan Han
    Ying Liu
    Adetunji T. Toriola
    Lindsay L. Peterson
    Graham A. Colditz
    Seung Il Kim
    Young Up Cho
    Byeong-Woo Park
    Yikyung Park
    Breast Cancer Research, 21
  • [44] Changes in Treatment Recommendations Based on the 21-Gene Recurrence Score Even in Node-Positive Patients
    Smith, J. Stanley
    Kass, Rena
    Kauffman, Gordon
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : 105 - 106
  • [45] Impact of the 21-gene recurrence score assay on chemotherapy decision making and outcomes for breast cancer patients with four or more positive lymph nodes
    Zhang, Qing-Hong
    Zhang, Wen-Wen
    Wang, Jun
    Lian, Chen-Lu
    Sun, Jia-Yuan
    He, Zhen-Yu
    Wu, San-Gang
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (18)
  • [46] Cost-benefit of the 21-gene Breast Cancer Recurrence Score Assay for Patients in Singapore
    Lopes, Gilberto de Lima
    Chien, Rebecca
    Hornberger, John
    BREAST JOURNAL, 2013, 19 (02): : 220 - 221
  • [47] Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario
    Levine, Mark N.
    Julian, Jim A.
    Bedard, Philippe L.
    Eisen, Andrea
    Trudeau, Maureen E.
    Higgins, Brian
    Bordeleau, Louise
    Pritchard, Kathleen I.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) : 1065 - +
  • [48] Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer
    Holowatyj, Andreana N.
    Cote, Michele L.
    Ruterbusch, Julie J.
    Ghanem, Kristina
    Schwartz, Ann G.
    Viguerm, Fawn D.
    Gorski, David H.
    Purrington, Kristen S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (07) : 652 - +
  • [49] The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
    Eiermann, W.
    Rezai, M.
    Kuemmel, S.
    Kuehn, T.
    Warm, M.
    Friedrichs, K.
    Schneeweiss, A.
    Markmann, S.
    Eggemann, H.
    Hilfrich, J.
    Jackisch, C.
    Witzel, I.
    Eidtmann, H.
    Bachinger, A.
    Hell, S.
    Blohmer, J.
    ANNALS OF ONCOLOGY, 2013, 24 (03) : 618 - 624
  • [50] Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26-30
    Park, Seho
    Han, Yunan
    Liu, Ying
    Toriola, Adetunji T.
    Peterson, Lindsay L.
    Colditz, Graham A.
    Kim, Seung Il
    Cho, Young Up
    Park, Byeong-Woo
    Park, Yikyung
    BREAST CANCER RESEARCH, 2019, 21 (01)